Home > Press > Frost & Sullivan Hosts Webinar: Can We Live Forever? Gauging the Future Trajectory of Medical Technology Development
Abstract:
WHEN:
Thursday, March 31, 2011 at 1 p.m. EDT
LOCATION:
Online, with free registration
SPEAKERS:
Venkat Rajan, industry analyst for Frost & Sullivan's Healthcare group Frost & Sullivan
Frost & Sullivan Hosts Webinar: Can We Live Forever? Gauging the Future Trajectory of Medical Technology Development
Posted on March 24th, 2011
While predominantly a topic for philosophical debate, the concept of immortality has made its way into scientific conversations due to buzz around major advances in biomedical research. This presentation will highlight and asses the current developmental lifecycle of a new breed of futuristic medical devices.
This briefing would be of interest to any individual or organization looking to gain a better understanding of the future trajectory of medical technology development.
Supporting Quotes
"Breakthroughs in dedicated medical device and other underlying technologies now making their way into the healthcare field are enabling unprecedented advancements in the fields of tissue engineering, cybernetics, nanotech, personalized medicine and artificial intelligence," said Venkat Rajan, Frost & Sullivan industry analyst. "Paradigm shifting biomedical advances once imagined in film and literature could be making their way to real world applications in the coming decade and beyond."
Supporting Resources
For more information about Frost & Sullivan's Healthcare practice, please visit: www.frost.com/healthcare
Registration
* To attend the briefing, email your full name, job title, company name, company telephone number, company email address and web site, city, state and country.
* Receive a recorded version of the briefing anytime by submitting the aforementioned contact details.
####
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents.
For more information, please click here
Contacts:
Britni Myers
Frost & Sullivan
+1.210.477.8481
Copyright © Marketwire
If you have a comment, please
Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
News and information
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
NanoInk, Inc. Assets To Be Sold May 18th, 2013
Beautiful "flowers" self-assemble in a beaker: Elaborate nanostructures blossom from a chemical reaction perfected at Harvard May 17th, 2013
Scientists capture first direct proof of Hofstadter butterfly effect May 17th, 2013
Announcements
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
NanoInk, Inc. Assets To Be Sold May 18th, 2013
NIA Public Briefing: Nanotechnology and the Council of Europe May 17th, 2013
Scientists capture first direct proof of Hofstadter butterfly effect May 17th, 2013
Events/Classes
Interactive Printed Products – New Applications Enabled by Organic and Printed Electronics May 16th, 2013
Nanometrics Announces Upcoming Investor Events May 14th, 2013
INSCX™ exchange to present a nanotechnology-based Emission Reduction Programme, Ankara, Turkey, June 2013 May 14th, 2013
VDMA: New “Photonics Industry Report 2013” presented May 14th, 2013
Life Extension/Cryonics
Conceptual Nanomedical Lipofuscin Removal Strategy April 29th, 2013
utsandiego.com November 22nd, 2012
Nanoparticles against aging October 3rd, 2012
Fancy retirement reset to the age of 900? December 17th, 2010